P

Inventor

HARRIS GREGORY D

US11 patents
⚠️ This page may combine multiple inventors who share the name “HARRIS GREGORY D”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

DU PONT MERCK PHARMA

3 patents
US5519143AMay 21, 1996

Process for the isolation and purification of an imidazole stereoisomer from a mixture of stereoisomers by selective precipitation

DU PONT MERCK PHARMA30 citations91
US5510495AApr 23, 1996

Process for the isolation and purification of ester functionalized imidazole intermediates by selective hydrolysis

DU PONT MERCK PHARMA10 citations72
US5530124AJun 25, 1996

Method for preparing cyclic ureas and their use for the synthesis of HIV protease inhibitors

DU PONT MERCK PHARMA5 citations57

ICI PLC

3 patents
US4723037AFeb 2, 1988

Process for making 1,3-dioxane derivatives

ICI PLC14 citations72
US5072008ADec 10, 1991

Manufacture of lactol derivatives

ICI PLC3 citations61
US5169974ADec 8, 1992

Process for manufacturing aryloxyaldehydes

ICI PLC3 citations60

ZENECA LTD

1 patent
US5492905AFeb 20, 1996

1-bolizazepin-2,5-diones

ZENECA LTD3 citations61

TEKTRONIX INC

1 patent
US4789789ADec 6, 1988

Event distribution and combination system

TEKTRONIX INC3 citations57

BRISTOL MYERS SQUIBB PHARMA

1 patent
US6555686B2Apr 29, 2003

Asymmetric synthesis of quinazolin-2-ones useful as HIV reverse transcriptase inhibitors

BRISTOL MYERS SQUIBB PHARMA0 citations46

BRISTOL MYERS SQUIBB PHARMA CO

1 patent
US6452000B2Sep 17, 2002

Preparation of asymmetric cyclic ureas through a monoacylated diamine intermediate

BRISTOL MYERS SQUIBB PHARMA CO1 citations45

DU PONT PHARM CO

1 patent
US6218534B1Apr 17, 2001

Preparation of asymmetric cyclic ureas through a monoacylated diamine intermediate

DU PONT PHARM CO0 citations45